Abstract
The polymerase chain reaction andHaeIII enzymatic digestion were used to study the seventh exon of the p53 gene in 29 primary and recurrent hepatomas in paraffin-embedded samples from 11 patients. The mutation rate of the p53 gene and its geno-types in samples of primary and recurrent tumours and multiple nodules were investigated. The cellular origins of hepatocellular carcinoma were analysed by p53 genotype. p53 mutation rates were found to be 69.0% (20/29) in the primary and recurrent tumours, 58.8% (10/17) in tumours with a single nodule and 83.3% (10/12) in tumours with multiple nodules. The p53 genotypes were found to be different in 6 pairs of primary and recurrent tumours, and another 5 pairs had the same p53 genotypes. The samples with multiple nodules in the same patients had the same p53 geno-types. Seven recurrences were of multicentric origin and four were of unicentric origin. It is suggested that the recurrent lesions developed from both unicentric and multicentric origins.
Similar content being viewed by others
Abbreviations
- HCC :
-
hepatocellular carcinoma
References
Bressac B, Kew M, Wands J, Ozturk M (1991) Selective G to T mutation of p53 gene in hepatocellular carcinoma from South Africa. Nature 350:429–431
Chen PJ, Chen DS, Lai MY, Chang MH, Huang GT, Yang PM, Sheu JC, Lee SC, Hsu HC, Sung JL (1989) Clonal origin of recurrent hepatocellular carcinoma. Gastroenterology 96: 527–529
Heyward NK, Walker GJ (1991) Hepatocellular carcinoma mutation. Nature 352:764–766
Hollstein M, Sidransky D, Volgelstein B, Harris CC (1991) p53 mutation in human cancers. Science 253:49–53
Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC (1991) Mutational hotspot in the p53 gene in human hepatocellular carcinoma. Nature 350:457–458
Hsu HC, Peng SY, Lai PL, Shen JC, Chen DS, Lin LI, Sun BI, Brutel TS (1994) Allelotype and loss of heterozygosity of p53 in primary and recurrent hepatocellular carcinoma: a study of 145 patients. Cancer 73:42–47
Levein AJ, Momand J, Finlay CA (1991) the p53 tumor suppressor gene. Nature 35:453–456
Liang XH, Loncarevic IF, Tang ZY, YU YQ, Zentgraf H, Schroder CH (1991) Resection of hepatocellular carcinoma: oligocentric origin of recurrent and multinodular tumours. J Gastroenterol Hepatol 6:77–81
Murakimi Y, Hayashi K, Hirihashi S, Kekiya T (1991) Aberration of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res 51:5520–5525
Nishida N, Fukuda Y, Kokuryu H, Toguchida T, Yandell DW, Ikenega M, Imura H, Ishizaki K (1993) Role and mutational heterogenecity of the p53 gene in hepatocellular carcinoma. Cancer Res 53:368–372
Oda T, Tsuda H, Scarpa A, Sakamoto M, Hirohashi S (1992) p53 gene mutation spectrum in hepatocellular carcinoma. Cancer Res 52:6358–6364
Ozturk M, Bressac B, Puisieux A, Kew M, Volkmann M, Bozcall S (1991) p53 mutation in hepatocellular carcinoma after aflatoxin exposure. Lancet 338:1356–1359
Qin LX, Tang ZY, LIu KD, Yie SL, HE B, Zhang Y, Zhou G (1995) The mutation between p53 and tumor invasiveness of hepatocellular carcinoma. Chin J Oncol 17:405–408 (in Chinese)
Simonetti RG, Camma C, Fiorello F, Politi F, Damica G, Pagliaro L (1991) Hepatocellular carcinoma: a worldwide problem and the major risk factor. Dig Dis Sci 36:962–972
Tang ZY, Yu YQ, Zhou XD (1984) An important approach to prolonging survival further after radical resection of AFP positive hepatocellular carcinoma. J Exp Clin Cancer Res 3:359–366
Unsal H, Yakilier C, Macceis C (1994) Genetical heterogenicity of hepatocellular carcinoma. Proc NaH Acid Sci USA 91:822
Author information
Authors and Affiliations
Additional information
This work was supported partially by China Medical Board Grant 93-583
Rights and permissions
About this article
Cite this article
He, B., Tang, ZY., Liu, KD. et al. Analysis of the cellular origin of hepatocellular carcinoma by p53 genotype. J Cancer Res Clin Oncol 122, 763–766 (1996). https://doi.org/10.1007/BF01209125
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01209125